Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab.
- DOI
- 10.1016/j.waojou.2023.100788
- Published
- 2023 Jun
- Container
- The World Allergy Organization journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.waojou.2023.100788,
title = {Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab.},
author = {Doan S and Papadopoulos NG and Lee JK and Leonardi S and Manti S and Lau S and Rondon C and Sharma V and Pleyer U and Jaumont X and Lazarewicz SB},
year = {2023},
journal = {The World Allergy Organization journal},
doi = {10.1016/j.waojou.2023.100788},
url = {https://doi.org/10.1016/j.waojou.2023.100788}
}RIS
TY - JOUR TI - Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab. AU - Doan S AU - Papadopoulos NG AU - Lee JK AU - Leonardi S AU - Manti S AU - Lau S AU - Rondon C AU - Sharma V AU - Pleyer U AU - Jaumont X AU - Lazarewicz SB PY - 2023 JO - The World Allergy Organization journal DO - 10.1016/j.waojou.2023.100788 UR - https://doi.org/10.1016/j.waojou.2023.100788 ER -
APA
S, D., NG, P., JK, L., S, L., S, M., S, L., C, R., V, S., U, P., X, J., & SB, L. (2023). Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab.. The World Allergy Organization journal. https://doi.org/10.1016/j.waojou.2023.100788
Source records
- pubmed · retrieved 2026-09-26T17:15:10.812Z